Colorectal Cancer Clinical Trial
Official title:
Impact of DietarY and LIfestyle Risk Factors on Colorectal Cancer Screening (IDYLIC Study). Is it Possible to Target Risk Subjects by Using a Predictive Score?
The main purpose of our project is to construct a lifestyle score based on a short questionnaire easy to complete and to validate it among participants in mass screening for colorectal cancer in Maine and Loire department over the next 2 years (2012 and 2013). We will evaluate the ability of our score to identify subjects with colorectal cancer diagnosed by the screening procedure (Hemoccult II ®, and colonoscopy if the test result is positive). Colorectal cancer will be the primary outcome for the assessment of the score's performance. The secondary endpoint will focus on colorectal adenomas diagnosed by the same procedure. Our secondary objectives are to test a second weighting system, evaluate the benefit in terms of predictive performance to add to the lifestyle score other dietary factors among that have a probable link with the risk of colorectal cancer, determine the acceptability of the questionnaire and to estimate by a cost-utility analysis the impact of applying a strategy of targeted screening using the developed score.
Background: The clinical value of early detection of colorectal cancer has been clearly
demonstrated. The evaluation in 23 pilot counties of the organized screening program for
colorectal cancer in France, that was widespread throughout the country in 2009, concluded
that results are satisfactory but should be improved especially in terms of sensitivity and
participation rates. Epidemiological studies show that apart from the hereditary factor and
age, the risk of colorectal cancer is mainly associated with lifestyle factors. The World
Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have
published jointly in 2007 an update of the scientific knowledge on the relationships between
nutritional factors (diet, physical activity) and the risk of cancer. This expert's report
confirms that, according to the available data, the risk of colorectal cancer is increased
in a convincing way with excessive consumption of alcohol, red meat and processed meat, and
among overweight people, especially for those with excess abdominal adiposity. Conversely,
the practice of regular physical activity has a protective effect. A recent meta-analysis
estimated colorectal cancer relative risks of each of the factors mentioned above, smoking
habits and other factors related to lifestyle (obesity, diabetes). This information helps to
consider now the development of a predictive score for colorectal cancer.
Objectives: The main purpose of our project is to construct a lifestyle score based on a
short questionnaire easy to complete and to validate it among participants in mass screening
for colorectal cancer in Maine and Loire department over the next 2 years (2012 and 2013).
We will evaluate the ability of our score to identify subjects with colorectal cancer
diagnosed by the screening procedure (Hemoccult II ®, and colonoscopy if the test result is
positive). Colorectal cancer will be the primary outcome for the assessment of the score's
performance. The secondary endpoint will focus on colorectal adenomas diagnosed by the same
procedure. Our secondary objectives are to test a second weighting system, evaluate the
benefit in terms of predictive performance to add to the lifestyle score other dietary
factors among that have a probable link with the risk of colorectal cancer, determine the
acceptability of the questionnaire and to estimate by a cost-utility analysis the impact of
applying a strategy of targeted screening using the developed score.
Organization: The project will be coordinated by the department of Gastroenterology and
Hepatology from Angers University Hospital. All data will be collected at the time of
participation in organized screening program for colorectal cancer. The management of data
collection will be done in close collaboration with the structure of screening in the Maine
et Loire, Cap Santé 49, so as part of a logistic organization that is already operational.
The identification of data that are specific to the project will be simplified by using for
each participant the same barcode as that for Hemoccult test. To develop a questionnaire
adapted to our objectives and a potential future use on large populations, we will rely on
the expertise and experience of a French Research Unit in Nutritional Epidemiology (UMR U557
INSERM / INRA / CNAM / Paris XIII University). In recent years, this team has developed
scores that assess compliance with the objectives or recommendations of the National
Nutrition and Health Program. The Unit also developed a food frequency questionnaire adapted
to the French population and has demonstrated the reproducibility and validity of this tool
compared to repeated 24 hours dietary records. We will select from this questionnaire the
items on the food groups that have an interest with the objectives of this project, our
score will be constructed on the basis of consumption of foods or food groups, not
nutrients. The statistical analysis will be conducted by the biostatisticians team from
Angers University Hospital.
Expected results: The purpose of the tool (the questionnaire and the system for calculating
the overall lifestyle score) is to help general practitioners to identify high risk subjects
in general population, regardless of familial predisposition, and to encourage these people
to participate in the national screening program. Associated with screening based on age,
this strategy may optimize colorectal cancer screening in France.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |